ARTICLE | Company News
Cellceutix infectious news
September 23, 2013 7:00 AM UTC
Cellceutix said it also plans to complete PolyMedix's application for an IND for a Phase II trial of brilacidin in oral mucositis and pursue Orphan Drug designation for the indication. Furthermore, Ce...